Stay updated on Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.5.4 was added, replacing the previous v3.5.3. This indicates a small update to the page metadata rather than a change to its substantive content.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page revision updated from v3.5.2 to v3.5.3, indicating a small version update to the study record page. The update does not alter the study details shown to users.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision: v3.5.2 was added and revision: v3.5.0 was removed.SummaryDifference0.0%

- Check65 days agoChange DetectedAdded a Publications entry for the Phase II study article: Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer with Clin Colorectal Cancer citation and DOI. The entry is automatically populated from PubMed.SummaryDifference0.3%

- Check73 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check101 days agoChange DetectedAdded system Revision: v3.4.2 and removed the funding notice Revision: v3.4.1. No study data or page content were changed; (To avoid being alerted by small changes, set an alert condition by clicking below.)SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.